Home » Business News » 2014 » December » December 17, 2014

Change in the number of votes relating to Biotie Therapies Corp.'s shares

December 17, 2014 - London

BIOTIE THERAPIES CORP.                Stock Exchange Release        17 December 2014 at 08:50 am

Change in the number of votes relating to Biotie Therapies Corp.'s shares

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed 15,000 Biotie shares held as treasury shares pursuant to the Stock Option Plan 2011.

After this conveyance, all 3,321,660 shares issued on 2 January 2014 and held in treasury for this purpose have been conveyed. Under the Stock Option Plan 2011, the owners of the stock options may subscribe for a maximum total of 7,401,000 shares and the owners of the Equity Incentive Plan 2011 may subscribe for a maximum total of 4,599,000 shares in the Company. Due to share issues already made pursuant to the Stock Option Plan 2011 and the Equity Incentive Plan 2011 (the "Plans"), forfeitures and some of the instruments based on the Plans having been left unallocated, a maximum of 5,472,375 shares may still be issued pursuant to the Plans.

The subscription price of EUR 0.01 per share has been fully paid by the employee and the EUR 150 funds received for the conveyance made will be credited to the Company's reserve for non-restricted equity.

The conveyed shares previously held as treasury shares have not carried any voting rights. The conveyance does not affect the number of registered shares. After the conveyances the changes are as follows:

Increase in number
 of outstanding
Total amount of
voting rights
Number of the
Company's share held
by the Group
Total number
of registered
15,000 450,696,015 5,336,383 456,032,398

Turku, 17 December 2014

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail:
NASDAQ OMX Helsinki Ltd
Main Media 

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biotie Therapies Oyj via Globenewswire



Comment on this story